Recent Updates
Recently added Catalysts
TWST Neutral Sentiment

Notice of Proposed Derivative Settlement: Twist Bioscience Corporation

Key Takeaway: Twist Bioscience Corporation announced a proposed settlement regarding derivative litigation. The case is currently in the United States District Court for the District of Delaware. Current record holders and beneficial owners of the company's common stock as of October 15, 2026, are notified about the settlement.

Market Sentiment Analysis

Full Press Release Details

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST): UNITED STATES DISTRICT COURT DISTRICT OF DELAWARE IN RE TWIST BIOSCIENCE CORPORATION DERIVATIVE LITIGATION Lead Case No. 1:23-cv-01048-MN SUMMARY NOTICE OF PROPOSED SETTLEMENT OF DERIVATIVE ACTION TO: ALL CURRENT RECORD HOLDERS AND BENEFICIAL OWNERS OF TWIST BIOSCIENCE CORPORATION (“TWIST” OR THE “COMPANY”) COMMON STOCK AS OF OCTOBER 15, 2026 (THE “RECORD DATE”). IF YOU WERE A RECORD OR BENEFICIAL OWNER O

Frequently Asked Questions

What is the proposed settlement about?

It concerns derivative litigation involving Twist Bioscience Corporation.

Who is affected by the settlement?

Current record and beneficial owners of Twist common stock as of October 15, 2026.

Where is the litigation taking place?

The case is in the United States District Court for the District of Delaware.

What is the record date for stockholders?

The record date is October 15, 2026.

Last updated: Nov 3, 2026